Publications

1. Ibrahim Alabbadi, Grainne Crealey, Michael Scott, Simon Baird, Tom Trouton, Jill Mairs and James McElnay. Impact of modified System of Objectified Judgment Analysis (SOJA) methodology on prescribing costs of ACEIs. Clinical Drug Investigation (2006); 26 (9): 485-94. Presented at the 8th International Society of PharmacoEconomics and Outcomes Research Annual European Congress, Florence, Italy (November 2005).
2. Mike Scott, Mark Timony, Jill Mairs, Grainne Crealey, Ibrahim Alabbadi, Rob Brenninkmeijer, Robert Janknegt and James McElnay. Safe Therapeutic Economic Pharmaceutical Selection (STEPS): development, introduction and use in Northern Ireland. Expert Opin. Pharmacother (2007) 8: S57-S63.
3. Mike Scott, Mark Timony, Jill Mairs,Grainne Crealey, Ibrahim Alabbadi, Rob Brenninkmeijer, Robert Janknegt and James McElnay. Matrix models and STEPS: concluding remarks: Expert Opin. Pharmacother (2007) 8(Suppl. 1): S65-S67.
4. Ibrahim Al-Abbadi, Abdelraouf Qawwas, Mahmoud Jaafreh, Taher Abosamen and Maisa Saket. One-year Assessment of Joint Procurement of Pharmaceuticals in the Public Health Sector in Jordan. (2009) Clinical Therapeutics. 31(6): 1335-43.
5. Ibrahim Al-Abbadi, Fadi Alkhateeb, Nile Khanfar, Bahaudin Mujtaba and Latif David. Pharmacy Students' Perceptions of the Teaching Evaluation Process in Jordan: Education, Business and Society: Contemporary Middle Eastern Issues. Vol. 2 No. 3, 2009 pp. 181-190.
6. Ibrahim Al-Abbadi 2007 ISPOR International Fellowship Award recipient report. ISPOR Connections-ISPOR Corner Vol. 15 (No.2), March/April 2009: page 11.
7. Ibrahim Al-Abbadi Health Care Equity Issues in the Middle East. ISPOR Connections-Policy Analysis Vol. 15 (No.4), July/August 2009: page 8-9.
8. Ibrahim Alabbadi, Grainne Crealey, Kathryn Turner, Therese Rafferty, Lynn Keenan, Penny Murray and James McElnay. Statin prescribing in Northern Ireland and England pre and post introduction of the Quality and Outcomes Framework. Pharm World & Sci (2010) 32 (1); 43-51.
9. Ali Al-Maaieh, Ahmad Oran and Ibrahim Alabbadi. Over-The -Counter Drugs’ Price De- regulation in Jordan: The Case of Paracetamol: Jordan Medical Journal (2010) 44 (2); 208-215.
10. Faris El-Dahiyat, Reem Kayyali and Ibrahim Alabbadi. A comparison of generic and originator brand drug prices between Jordan and the United Kingdom. Jordan Journal of Pharmaceutical Sciences (2011) 4 (1); 35-48.
11. Kalipso Chalkidou, Joanne Lord, Nour A. Obeidat, Ibriham A. Alabbadi, Adrian G. Stanley, Rania Bader, Aiman Momani, Rachel M. O’Mahony, Lara Qatami and Derek Cutler. Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care: International Journal for Technology Assessment in Healthcare (2011), 27 (2), 151-158.
12. Ibrahim Alabbadi, Renad Al-Momani and Hala Khyami-Horani. Impact of electronic academic staff websites for scientific research documentation on world universities ranking: University of Jordan challenge; 11th International Educational Technology Conference, Istanbul University, Istanbul, TURKEY (May 2011): Proceedings Book, Volume 1: 597-600.
13. Ibrahim Alabbadi. Cost impact of purchasing pharmaceuticals jointly in the public health sector in Jordan. (2011) Jordan Journal of Pharmaceutical Sciences,Vol. 4, No. 2: 97-104.
14. Ryan B Abbott, Rania Bader, Lina Bajjali, Taher Abu ElSamen,Thamer Obeidat, Hanan Sboul, Mustafa Shwayat and Ibrahim Alabbadi. The price of medicines in Jordan: the cost of trade-based intellectual property. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector (2012), 9(2) 75–85.
15. Abrar Ghaith, Hani Aldmour and Ibrahim Alabbadi. Investigating the effect of pharmaceutical companies' gifts on doctors' prescribing behavior in Jordan. European Journal of Social Sciences, Volume 36 Issue 4, Jan 2013, pp.528-536.
16. Eiman Abulhaj, Amjad Abu Elsamen and Ibrahim Alabbadi. Investigating the factors affecting doctor's prescribing behavior in Jordan: Anti-hypertensive drugs as an example. European Journal of Social Sciences, Volume 38 Issue 3, May 2013, pp. 380-391.
17. Ibrahim Alabbadi, Azmi Mahafza, Mousa M. Al-Abbadi and Amir Bakir. Investment opportunities in health: Feasibility of building an American private hospital in Jordan. European Journal of Social Sciences, Volume 40 Issue 2, Oct. 2013, pp. 312-329.
18. Ibrahim Alabbadi, Ryan Abbott and Deema Jaber. Jordanian stakeholder attitudes toward generic substitution. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. (2014) vol. 11, 1-2: pp. 24-34.
19. Rand Alawi and Ibrahim Alabbadi. Investigating the effect of data exclusivity on the pharmaceutical sector in Jordan. Jordan Journal of Pharmaceutical Sciences, Volume 8, No. 2, 2015 pp. 70-81.
20. Hamsa Al-Aqqad, Muhammed Al-Zweiri & Ibrahim Alabbadi: Investigating physicians’ perception of pharmaceutical trade names in Jordan’s private market: simulated and real-world setting approaches. Pharm Med (2015) 29, 3:169-178.
21. Zolta´n Kalo, Ibrahim Alabbadi, Ola Ghaleb Al Ahdab et al. Implications of external price referencing of pharmaceuticals in Middle East countries. Expert Rev. Pharmacoecon. Outcomes Res. (2015) 15, 6: 993-998.
22. A. Agil, E. K. Elmahallawy, J. M. Rodríguez-Ferrer, A. Adem, S. M. Bastaki, I. Al-abbadi, Y. A. Fino Solano and M. Navarro-Alarcón. Melatonin increases intracellular calcium in the liver, muscle, white adipose tissues and pancreas of diabetic obese rats. (2015) Food Funct., 6, 2671-2678.
23. Ibrahim Alabbadi and Eman A Hammad. The impact of generic entry and price competition in Jordanian public health sector. (2015) Journal of Generic Medicines. 11, 3-4: 123-128.
24. Ibrahim Alabbadi: Budget impact of adding one Dipeptidyl peptidase-4 inhibitor to Ministry of Health Jordan tender list in the treatment of Type II Diabetes Mellitus. (2015) Jordan Journal of Pharmaceutical Sciences 8, 3: 173-180.
25. Daoud Al-Badriyeh, M. Fahey, I. Alabbadi, A. Al-Khal, and M. Zaidan. Statin Selection in Qatar Based on Multi-Indication Pharmacotherapeutic Multi-Criteria Scoring, and Clinician Preference. (2015) Clinical Therapeutics 37, 12: 2798-2810.
26. Ibrahim Alabbadi: Pharmaceutical business and Pharmaceutical industry: new tracks in pharmacy education initiated in Jordan. (2015) Jordan Journal of Pharmaceutical Sciences. 8, 3: 217-227.
27. Qais Al-Efan, Shaymaa Al-Imam, Tareq Mukattash, Nizar Mhaidat, Ibrahim Alabbadi and Karen Rascati. Pharmacoeconomics Education in WHO Eastern Mediterranean Region. Currents in Pharmacy Teaching and Learning (2015), 7, 6: 819-825.
28. Ibrahim Alabbadi. Impact of hosting Syrians on the availability of medicines in the Jordanian public health sector. (2015) European Journal of Social Sciences. Volume 48 Issue 4, pp. 459-467.
29. Sumaya Abuloha, Ibrahim Alabbadi, Abla Albsoul-Younes, Nidal Younes and Ayman Zayed. The role of clinical pharmacist in initiation and/or dose adjustment of insulin therapy in diabetic patients in outpatient clinic in Jordan. (2016) Jordan Journal of Pharmaceutical Sciences, Vol. 9, No. 1, 33-50.
30. Eman Hammad, Taissir Fardous and Ibrahim Alabbadi. Costs of hospital services: a case study from Jordan. Int J Health Plann Mgmt 2016 Published online in Wiley Online Library.
31. Daoud Al-Badriyeh, I. Alabbadi, M. Fahey, A. Al-Khal, and M. Zaidan. Multi-indication pharmacotherapeutic multi-criteria scoring model for the comparative formulary inclusion of proton pump inhibitors in Qatar. (2016) Clinical Therapeutics. Volume 38, Issue 5, Pages 1158–1173.
32. Shallya Omar, Abla-Bsoul Younes and Ibrahim Alabbadi. Hypoglycemia fear among diabetics. Jordan Journal of Pharmaceutical Sciences, Volume 9, No. 2, 2016: P. 77-87
33. Albsoul-Younes A, Gharaibeh L, Murtaja AA, Masri A, Alabbadi I, Al-Qudah AA. Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan. Neurosciences (Riyadh). 2016 Jul; 21(3): 264-267.
34. Amirah Daher and Ibrahim Alabbadi. Investigating the Effect of Syrian Refugees on the Pharmaceutical Sector in Jordan. Archives of Iranian Medicine. Aug 2017; Vol. 20 (8): 538-546.
35. Ahmed Albarqawi, Amjad Abu Elsamen, Amirah Daher and Ibrahim Alabbadi. Examining the Effect OF Pharmaceutical Personal Selling on the Physicians’ Prescribing Choice of Medicine in Jordan. Academia Journal of Scientific Research. Oct 2016; Vol. 4(10): 337-344.
36. Abdelkarim A. Al-Qudah, Abla Albsoul-Younes, Amira T. Masri, Samah K. AbuRahmah, Ibrahim A. Alabbadi, Omar A. Nafi, Lubna F. Gharaibeh, Amer A. Murtaja, Lina H. Al-Sakran, Haya A. Arabiat, Abdallah A. Al-Shorman. Type and etiology of pediatric epilepsy in Jordan: a multi-center study. Neurosciences 2017; Vol. 22 (4): 267-273.